ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710342 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710342; 2) Community: the network communities that were significantly associated with the response to NSC 710342; 3) Molecule: the relationships between components within communities and NSC 710342; 4) MDR: the compounds that were significantly associated with the NSC 710342.

NSC Compound Enrichment Correlation
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.049093561024907 0.22806857
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.0490935610249072 -0.13307327
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0490935610249072 0.4871497
NSC 638241 Null 0.0490935610249072 0.40205164
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0490935610249072 0.45809266
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.0490935610249072 0.43589116
NSC 646159 Null 0.0490935610249072 0.53825884
NSC 659390 Null 0.0490935610249072 0.4813055
NSC 661832 Null 0.0490935610249072 0.52119855
NSC 666123 Null 0.0490935610249072 0.33107549
Total:89  Current:88    [First] [Prev] [Next] [Last]